BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 18559090)

  • 1. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
    Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
    Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer.
    Ahmed MA; Aleskandarany MA; Rakha EA; Moustafa RZ; Benhasouna A; Nolan C; Green AR; Ilyas M; Ellis IO
    Breast Cancer Res Treat; 2012 Jun; 133(3):979-95. PubMed ID: 22119938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
    Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.
    Lin Y; Zhong Y; Guan H; Zhang X; Sun Q
    J Exp Clin Cancer Res; 2012 Jul; 31(1):59. PubMed ID: 22762532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
    Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
    Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.
    Buess M; Rajski M; Vogel-Durrer BM; Herrmann R; Rochlitz C
    Neoplasia; 2009 Oct; 11(10):987-1002. PubMed ID: 19794958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
    Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
    BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
    Park SY; Lee HE; Li H; Shipitsin M; Gelman R; Polyak K
    Clin Cancer Res; 2010 Feb; 16(3):876-87. PubMed ID: 20103682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
    Marotta LL; Almendro V; Marusyk A; Shipitsin M; Schemme J; Walker SR; Bloushtain-Qimron N; Kim JJ; Choudhury SA; Maruyama R; Wu Z; Gönen M; Mulvey LA; Bessarabova MO; Huh SJ; Silver SJ; Kim SY; Park SY; Lee HE; Anderson KS; Richardson AL; Nikolskaya T; Nikolsky Y; Liu XS; Root DE; Hahn WC; Frank DA; Polyak K
    J Clin Invest; 2011 Jul; 121(7):2723-35. PubMed ID: 21633165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
    Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
    Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas.
    Perrone G; Gaeta LM; Zagami M; Nasorri F; Coppola R; Borzomati D; Bartolozzi F; Altomare V; Trodella L; Tonini G; Santini D; Cavani A; Muda AO
    PLoS One; 2012; 7(9):e43110. PubMed ID: 23028444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.